Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Danshen Sanjie is a traditional Chinese medicine (TCM) formulation that contains danshen (Salvia miltiorrhiza) as its primary active ingredient. Danshen, also known as Chinese red sage, is widely used in TCM for its purported effects on promoting blood circulation, resolving blood stasis, and reducing inflammation. The "Sanjie" in the name suggests a multi-herb combination aimed at dispersing masses or resolving accumulations, though specific additional ingredients may vary by manufacturer and region. The mechanism of action of Danshen-based formulations involves multiple bioactive compounds that exhibit vasodilatory effects, antiplatelet activity (blood thinning), anti-inflammatory properties, and antioxidant actions. These mechanisms are believed to underlie their use in cardiovascular diseases such as angina pectoris and stroke[1][2][3]. Clinical studies suggest potential benefits for vascular cognitive impairment and inflammatory conditions like IBD; however, high-quality evidence remains limited[3][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on danshen sanjie.